Analysis of correlation between cerebral perfusion and KIM score of white matter lesions in patients with Alzheimer's disease

References

• Kitamura A, Saito S, Maki T, et al. Gradual cerebral hypoperfusion in spontaneously hypertensive rats induces slowly evolving white matter abnormalities and impairs working memory. J Cereb Blood Flow Metab. 2016;36:9. doi:10.1177/0271678X15606717
   Web of Science ®Google Scholar
• Lacalle-Aurioles M, Navas-Sanchez FJ, Aleman-Gomez Y, et al. The disconnection hypothesis in Alzheimer’s disease studied through multimodal magnetic resonance imaging: structural, perfusion, and diffusion tensor imaging. J Alzheimers Dis Rep. 2016;50(4):1051–1064. doi:10.3233/JAD-150288
   Google Scholar
• Prins ND, van Dijk EJ, den Heijer T, et al. Cerebral white matter lesions and the risk of dementia. Arch Neurol. 2004;61(10):1531–1534. doi:10.1001/archneur.61.10.153115477506
   PubMed Web of Science ®Google Scholar
• Yoshita M, Fletcher E, Harvey D, et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology. 2006;67(12):2192–2198. doi:10.1212/01.wnl.0000249119.95747.1f17190943
   PubMed Web of Science ®Google Scholar
• Zupan M. Pathogenesis of Leukoaraiosis: A Review. 2016.
   Google Scholar
• Benedictus MR, van Harten AC, Leeuwis AE, et al. White matter hyperintensities relate to clinical progression in subjective cognitive decline. Stroke. 2015;46(9):2661–2664. doi:10.1161/STROKEAHA.115.00947526173729
   PubMed Web of Science ®Google Scholar
• Boyle PA, Yu L, Fleischman DA, et al. White matter hyperintensities, incident mild cognitive impairment, and cognitive decline in old age. Ann Clin Transl Neurol. 2016;3(10):791–800. doi:10.1002/acn3.34327752514
   PubMed Web of Science ®Google Scholar
• Kloppenborg RP, Nederkoorn PJ, Geerlings MI, van den Berg E. Presence and progression of white matter hyperintensities and cognition: a meta-analysis. Neurology. 2014;82(23):2127–2138. doi:10.1212/WNL.000000000000050524814849
   PubMed Web of Science ®Google Scholar
• Tosto G, Zimmerman ME, Carmichael OT, Brickman AM. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 2014;71(7):872–877. doi:10.1001/jamaneurol.2014.66724821476
   PubMed Web of Science ®Google Scholar
• van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP. White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer’s disease: a domain-specific meta-analysis. J Alzheimers Dis Rep. 2018;63(2):515–527. doi:10.3233/JAD-170573
   Google Scholar
• Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666. doi:10.1136/bmj.c366620660506
   PubMed Web of Science ®Google Scholar
• Richter N, Michel A, Onur OA, et al. White matter lesions and the cholinergic deficit in aging and mild cognitive impairment. Neurobiol Aging. 2017;53:27–35. doi:10.1016/j.neurobiolaging.2017.01.01228208063
   PubMed Web of Science ®Google Scholar
• van Straaten EC, Harvey D, Scheltens P, et al. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol. 2008;255(9):1302–1308. doi:10.1007/s00415-008-0874-y18825439
   PubMed Web of Science ®Google Scholar
• Bracco L, Piccini C, Moretti M, et al. Alzheimer’s disease: role of size and location of white matter changes in determining cognitive deficits. Dement Geriatr Cogn Disord. 2005;20(6):358–366. doi:10.1159/00008856216192726
   PubMed Web of Science ®Google Scholar
• De Groot JC, De Leeuw FE, Oudkerk M, et al. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002;52(3):335–341. doi:10.1002/ana.1029412205646
   PubMed Web of Science ®Google Scholar
• Feng L, Ye N, Wang JF, Wang SN, Zhang YM. The relationship of white matter lesions location and cognitive function in leukoaraisosis patients. Chin J Behav Med Brain Sci. 2018;27(1):26–30.
   Google Scholar
• Silbert LC, Nelson C, Howieson DB, Moore MM, Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology. 2008;71(2):108–113. doi:10.1212/01.wnl.0000316799.86917.3718606964
   PubMed Web of Science ®Google Scholar
• Soriano-Raya JJ, Miralbell J, Lopez-Cancio E, et al. Deep versus periventricular white matter lesions and cognitive function in a community sample of middle-aged participants. J Int Neuropsychol Soc. 2012;18(5):874–885. doi:10.1017/S135561771200067722687604
   PubMed Web of Science ®Google Scholar
• Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR Am J Roentgenol. 1987;149(2):351–356. doi:10.2214/ajr.149.2.3513496763
   PubMed Web of Science ®Google Scholar
• Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry. 2008;64(4):273–280. doi:10.1016/j.biopsych.2008.03.02418471801
   PubMed Web of Science ®Google Scholar
• Gao J, Cheung RT, Chan YS, Chu LW, Mak HK, Lee TM. The relevance of short-range fibers to cognitive efficiency and brain activation in aging and dementia. PLoS One. 2014;9(4):e90307. doi:10.1371/journal.pone.009030724694731
   PubMed Web of Science ®Google Scholar
• Dadar M, Maranzano J, Ducharme S, Collins DL. White matter in different regions evolves differently during progression to dementia. Neurobiol Aging. 2019;76:71–79. doi:10.1016/j.neurobiolaging.2018.12.00430703628
   PubMed Web of Science ®Google Scholar
• McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association Workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):263–269. doi:10.1016/j.jalz.2011.03.00521514250
   PubMed Web of Science ®Google Scholar
• Wu O, Ostergaard L, Weisskoff RM, Benner T, Rosen BR, Sorensen AG. Tracer arrival timing-insensitive technique for estimating flow in MR perfusion-weighted imaging using singular value decomposition with a block-circulant deconvolution matrix. Magn Reson Med. 2003;50(1):164–174. doi:10.1002/mrm.1052212815691
   PubMed Web of Science ®Google Scholar
• Staals J, Booth T, Morris Z, et al. Total MRI load of cerebral small vessel disease and cognitive ability in older people. Neurobiol Aging. 2015;36(10):2806–2811. doi:10.1016/j.neurobiolaging.2015.06.02426189091
   PubMed Web of Science ®Google Scholar
• de la Torre JC. Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol Res. 2004;26(5):517–524. doi:10.1179/01616410422501625415265269
   PubMed Web of Science ®Google Scholar
• Moran C, Phan TG, Srikanth VK. Cerebral small vessel disease: a review of clinical, radiological, and histopathological phenotypes. Int J Stroke. 2012;7(1):36–46. doi:10.1111/j.1747-4949.2011.00725.x22111922
   PubMed Web of Science ®Google Scholar
• Breteler MM. Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging. 2000;21(2):153–160.10867200
   PubMed Web of Science ®Google Scholar
• Chubykin AA, Roach EB, Bear MF, Shuler MG. A cholinergic mechanism for reward timing within primary visual cortex. Neuron. 2013;77(4):723–735. doi:10.1016/j.neuron.2012.12.03923439124
   PubMed Web of Science ®Google Scholar
• de Groot JC, de Leeuw FE, Oudkerk M, Hofman A, Jolles J, Breteler MM. Cerebral white matter lesions and subjective cognitive dysfunction: the Rotterdam scan study. Neurology. 2001;56(11):1539–1545. doi:10.1212/wnl.56.11.153911402112
   PubMed Web of Science ®Google Scholar
• Dickstein DL, Walsh J, Brautigam H, Stockton SD Jr, Gandy S, Hof PR. Role of vascular risk factors and vascular dysfunction in Alzheimer’s disease. Mt Sinai J Med. 2010;77(1):82–102. doi:10.1002/msj.2015520101718
   PubMedGoogle Scholar
• Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer’s disease: shadows and lights. J Alzheimers Dis Rep. 2011;23(3):375–389. doi:10.3233/JAD-2010-090700
   Google Scholar
• Lee YC, Liu RS, Liao YC, et al. Statistical parametric mapping of brain SPECT perfusion abnormalities in patients with Alzheimer’s disease. Eur Neurol. 2003;49(3):142–145. doi:10.1159/00006908612646756
   PubMed Web of Science ®Google Scholar
• Ma HR, Pan PL, Sheng LQ, et al. Aberrant pattern of regional cerebral blood flow in Alzheimer’s disease: a voxel-wise meta-analysis of arterial spin labeling MR imaging studies. Oncotarget. 2017;8(54):93196–93208. doi:10.18632/oncotarget.2147529190989
   PubMedGoogle Scholar
• Nitrini R, Buchpiguel CA, Caramelli P, et al. SPECT in Alzheimer’s disease: features associated with bilateral parietotemporal hypoperfusion. Acta Neurol Scand. 2000;101(3):172–176.10705939
   PubMed Web of Science ®Google Scholar
• Zhang N, Gordon ML, Goldberg TE. Cerebral blood flow measured by arterial spin labeling MRI at resting state in normal aging and Alzheimer’s disease. Neurosci Biobehav Rev. 2017;72:168–175. doi:10.1016/j.neubiorev.2016.11.02327908711
   PubMed Web of Science ®Google Scholar
• OSullivan M, Lythgoe DJ, Pereira AC, et al. Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis. Neurology. 2002;59(3):321–326. doi:10.1212/wnl.59.3.32112177363
   PubMed Web of Science ®Google Scholar
• Holland CM, Smith EE, Csapo I, et al. Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke. 2008;39(4):1127–1133. doi:10.1161/STROKEAHA.107.49743818292383
   PubMed Web of Science ®Google Scholar
• Makedonov I, Black SE, MacIntosh BJ. Cerebral small vessel disease in aging and Alzheimer’s disease: a comparative study using MRI and SPECT. Eur J Neurol. 2013;20(2):243–250. doi:10.1111/j.1468-1331.2012.03785.x22742818
   PubMed Web of Science ®Google Scholar
• Bridges LR, Andoh J, Lawrence AJ, et al. Blood-brain barrier dysfunction and cerebral small vessel disease (arteriolosclerosis) in brains of older people. J Neuropathol Exp Neurol. 2014;73(11):1026–1033. doi:10.1097/NEN.000000000000012425289893
   PubMed Web of Science ®Google Scholar
• Huang J, Li J, Feng C, et al. Blood-brain barrier damage as the starting point of leukoaraiosis caused by cerebral chronic hypoperfusion and its involved mechanisms: effect of agrin and aquaporin-4. Biomed Res Int. 2018;2018:2321797. doi:10.1155/2018/232179729682525
   PubMed Web of Science ®Google Scholar
• Austin BP, Nair VA, Meier TB, et al. Effects of hypoperfusion in Alzheimer’s disease. J Alzheimers Dis Rep. 2011;26(Suppl 3):123–133. doi:10.3233/JAD-2011-0010
   Google Scholar